Your browser doesn't support javascript.
Cancer patients with COVID-19: a retrospective study of 51 patients in the district of Piacenza, Northern Italy.
Cavanna, Luigi; Citterio, Chiara; Toscani, Ilaria; Franco, Cosimo; Magnacavallo, Andrea; Caprioli, Serena; Cattadori, Evelina; Nunzio, Camilla Di; Pane, Roberto; Schiavo, Roberta; Biasini, Claudia; Ambroggi, Massimo.
  • Cavanna L; Oncology & Haematology Department, Oncology Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Citterio C; Oncology & Haematology Department, Oncology Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Toscani I; Oncology & Haematology Department, Oncology Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Franco C; Respiratory Intensive Care Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Magnacavallo A; Emergency Department, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Caprioli S; Administration Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Cattadori E; Research & Innovation Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Nunzio CD; Oncology & Haematology Department, Oncology Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Pane R; Pharmacy Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Schiavo R; Pathology Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Biasini C; Oncology & Haematology Department, Oncology Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
  • Ambroggi M; Oncology & Haematology Department, Oncology Unit, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
Future Sci OA ; 7(1): FSO645, 2020 Nov 24.
Article in English | MEDLINE | ID: covidwho-972690
ABSTRACT

BACKGROUND:

Cancer patients are considered a highly fragile group in the current coronavirus disease 2019 (COVID-19) pandemic. MATERIAL &

METHODS:

In this study, patients with COVID-19 and cancer, hospitalized in Piacenza, Italy, from 4 April to 4 May 2020 were included. Risk factors for death were analyzed.

RESULTS:

Fifty-one COVID-19 cancer patients were included, of which the median age was 71.02 years (range 51-86) and 70.59% were male. Cancer types included gastrointestinal (25.49%), genitourinary (25.49%) and lung (23.53%). Forty-five (88.24%) patients received hydroxychloroquine-based therapy. In addition, 25 of 51 patients died (49%) 12 of 51 (23.53%) owing to cancer and 13 of 51 (25.49%) owing to COVID-19.

CONCLUSION:

The risks for death were related to later onset of treatment for COVID-19, severe/critical COVID-19, age, elevated basal CRP and elevated lactate dehydrogenase.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Future Sci OA Year: 2020 Document Type: Article Affiliation country: Fsoa-2020-0157

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Future Sci OA Year: 2020 Document Type: Article Affiliation country: Fsoa-2020-0157